Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Dialogues in Clinical Neuroscience|July 14, 2010
Drug treatment of obsessive-compulsive disorderMichael KellnerDialogues in Clinical Neuroscience|January 26, 2012
Experimental panic provocation in healthy man-a translational role in anti-panic drug development?Michael KellnerEuropean Journal of Pharmacology|February 15, 2008
Mineralocorticoid receptors in brain, in health and disease: possibilities for new pharmacotherapyMichael Kellner, Klaus WiedemannExpert Review of Neurotherapeutics|October 9, 2009
Natriuretic peptides and panic disorder: therapeutic prospectsMichael Kellner, Holger Jahn, Klaus WiedemannCurrent Pharmaceutical Design|May 29, 2012
Panicogens in patients with Post-Traumatic Stress Disorder (PTSD)Christoph Muhtz, Klaus Wiedemann, Michael KellnerJournal of Clinical Psychology|November 28, 2002
Salivary cortisol levels and the cortisol response to dexamethasone before and after EMDR: a case reportRuth Heber, Michael Kellner, Rachel YehudaMaterials (Basel, Switzerland)|February 15, 2022
Rotating Directional Solidification of Ternary Eutectic Microstructures in Bi-In-Sn: A Phase-Field StudyKaveh Dargahi Noubary, Michael Kellner, Britta NestlerThe Journal of Nervous and Mental Disease|June 17, 2014
Perceptual properties of obsessive thoughts are associated with low insight in obsessive-compulsive disorderSteffen Moritz, Marike Claussen, Marit Hauschildt, et al.Psychiatry Research|May 15, 2012
Non-response of cortisol during stressful exposure therapy in patients with obsessive-compulsive disorder--preliminary resultsMichael Kellner, Klaus Wiedemann, Alexander Yassouridis, et al.Acta Psychiatrica Scandinavica|April 17, 2002
Longitudinal course of salivary cortisol in post-traumatic stress disorderMichael Kellner, Rachel Yehuda, Josef Arlt, et al.Pageof 9